Mr. Ciarán Breen:

I will not give it. I will give it, obviously, when I write in with the general mass actions. It would be in the aggregate, but I would not give it for the particular cohort of cases. It may not make sense to give it because our estimate is based on, for example, things like non-disclosure of the audit results and the likely level of general damages coming from that, or the possibility, like we had in the Ruth Morrissey case, where we get a clinical negligence case, separate from the screening and so on. Many of these will be taken care of from the ex gratiascheme that has been set up and the tribunal when it is set up. It will change quite a bit; it is quite dynamic.